Department of Pediatrics, Chung-Ang University Hospital, Seoul, Korea.
InfoBoss Inc., Seoul, Korea.
J Korean Med Sci. 2021 Mar 1;36(8):e58. doi: 10.3346/jkms.2021.36.e58.
Human breast milk (HBM) contains optimal nutrients for infant growth. Probiotics are used to prevent disease and, when taken by the mother, they may affect infant microbiome as well as HBM. However, few studies have specifically investigated the effect of probiotic intake by the mother on HBM and infant microbiota at genus/species level. Therefore, we present a comprehensive analysis of paired HBM and infant feces (IF) microbiome samples before and after probiotic intake by HBM-producing mothers.
Lactating mothers were administered with (n = 9) or capsules (n = 9), for 2 months; or no probiotic (n = 7). Paired HBM and IF samples were collected before and after treatment and analyzed by next-generation sequencing.
Forty-three HBM and 49 IF samples were collected and sequenced. Overall, in 43 HBM samples, 1,190 microbial species belonging to 684 genera, 245 families, 117 orders, and 56 classes were detected. In 49 IF samples, 372 microbial species belonging to 195 genera, 79 families, 42 orders, and 18 classes were identified. Eight of 20 most abundant genera in both HBM and IF samples overlapped: (14.42%), , , and , which were highly abundant in the HBM samples; and (27.397%), , and , which were highly abundant in the IF samples. Several major bacterial genera and species were detected in the HBM and IF samples after probiotic treatment, illustrating complex changes in the microbiomes upon treatment.
This is the first Korean microbiome study in which the effect of different probiotic intake by the mother on the microbiota in HBM and IF samples was investigated. This study provides a cornerstone to further the understanding of the effect of probiotics on the mother and infant microbiomes.
人乳(HBM)含有婴儿生长所需的最佳营养成分。益生菌用于预防疾病,当母亲服用时,它们可能会影响婴儿的微生物组以及 HBM。然而,很少有研究专门调查母亲摄入益生菌对 HBM 和婴儿属/种水平微生物组的影响。因此,我们提出了一项综合分析,即在 HBM 产生的母亲摄入益生菌前后,对 HBM 和婴儿粪便(IF)微生物组样本进行配对分析。
给哺乳期母亲服用(n = 9)或(n = 9)胶囊,持续 2 个月;或不服用益生菌(n = 7)。在治疗前后采集 HBM 和 IF 配对样本,并通过下一代测序进行分析。
共采集 43 份 HBM 和 49 份 IF 样本并进行测序。总体而言,在 43 份 HBM 样本中,检测到属于 684 属、245 科、117 目和 56 纲的 1190 种微生物。在 49 份 IF 样本中,鉴定出属于 195 属、79 科、42 目和 18 纲的 372 种微生物。HBM 和 IF 样本中 20 个最丰富的属中有 8 个重叠:(14.42%)、、、和,这些菌属在 HBM 样本中高度丰富;和(27.397%)、、和,这些菌属在 IF 样本中高度丰富。在益生菌治疗后,HBM 和 IF 样本中检测到几个主要的细菌属和种,说明了微生物组在治疗后发生了复杂的变化。
这是第一项研究母亲摄入不同益生菌对 HBM 和 IF 样本中微生物组影响的韩国微生物组研究。本研究为进一步了解益生菌对母婴微生物组的影响奠定了基础。